Cancer Pharmacology
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 547
Special Issue Editor
Interests: cancer cell biology; cancer pharmacology; anticancer drug; drug resistance; signal transduction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer pharmacology is a dynamic and rapidly advancing field, driving the discovery and development of novel therapies to overcome cancer. This Special Issue showcases cutting-edge progress in drug development, molecular targeting, and personalized medicine, providing novel insights into overcoming drug resistance and enhancing therapeutic outcomes. We invite contributions spanning a broad spectrum of topics, including, but not limited to, the following:
- Mechanisms of anticancer drugs and drug resistance;
- Targeted therapies and precision medicine;
- Immunopharmacology and cancer immunotherapy;
- Innovative drug delivery systems;
- Pharmacogenomics and biomarker discovery;
- Combination therapies and synergistic drug interactions;
- Preclinical and clinical oncology research.
By highlighting these key areas, this Special Issue aims to foster collaboration and accelerate breakthroughs in cancer treatment.
We welcome original research articles, reviews, and short communications that encompass fundamental and applied research in cancer pharmacology. We are particularly interested in studies that employ cutting-edge technologies, such as multi-omics approaches, high-throughput screening, and computational modeling, to advance our understanding of drug mechanisms and optimize therapeutic outcomes.
By bringing together diverse perspectives, this Special Issue seeks to foster innovation and collaboration in the fight against cancer. We invite researchers and clinicians to contribute their latest findings and insights to this important collection.
Prof. Dr. Zhi Shi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer pharmacology
- anticancer drug
- cancer chemotherapy
- targeted therapy
- cancer immunotherapy
- combination therapy
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
